Introduction

During early stages of development, Kilimanjaro Christian Medical University College (KCMUCo) research activities operated under the Kilimanjaro Christian Medical Centre which was established by the Good Samaritan Foundation in 1971. In 1997, the College became one of the six constituent colleges of the Tumaini University of the Evangelical Lutheran Church of Tanzania and took over some research activities including malaria. Malaria Research activities at KCMUCo were intensified from 2002 after the establishment of Joint Malaria Program (JMP). JMP is an umbrella organisation that promotes and facilitates collaborative research on malaria between the member institutions

JMP Collaborating Institutions

• Kilimanjaro Christian Medical University College (KCMUCo), Tumaini University, Moshi, Tanzania
• London School of Hygiene and Tropical Medicine (LSHTM), London, UK
• National Institute for Medical Research (NIMR), Tanzania.
• The Centre for Medical Parasitology (CMP), University of Copenhagen, Denmark

Initial activities of JMP were financially supported by ‘Gates Malaria Partnership program’ coordinated by the LSHTM. Some of the research activities centered on Laboratory (WHO-Phase I) and field (WHO-Phase II) evaluation of insecticides efficacy. Further research studies along this line were taken up by PAMVERC after its establishment as a program of KCMUCo in 2008.

• With support from IVCC, ITF facility in Moshi went through a process of accreditation
• The KCMUCo-PAMVERC Test Facility is the first vector control facility in Africa to achieve OECD GLP accreditation status.
• Received Certificate of Compliance (No.G0023) from South African National Accreditation System (SANAS)

Vision Statement

Accelerating development of new vector control tools and strengthening research capacity through product development and evaluation

Mission Statement

Delivering the highest level of excellence as an OECD GLP-compliant Test Facility in evaluation of vector control tools for research collaborators, industrial partners and regulatory authorities.

Objectives of PAMVERC

• To carry out laboratory screening of novel insecticide formulations
• To facilitate the development of insecticides for indoor residual spraying against mosquitoes and in particular, malaria vectors
• To carry out laboratory (Phase I) and Phase II (semi-filed) experimental hut evaluations of vector control tools including nets and IRS
• To perform large-scale field trials (Phase III) of vector control tools including indoor residual spraying, long lasting insecticide nets, blankets, wall liners, repellents and Artificial Targeted Sugar Bait
• To support training of students through short or long-term attachments to ongoing research